EVENTS & PRESENTATIONS

EVENTS & UPDATES

There are currently no events to display.

Presentations

Date Title

Archived Events

Date Event Details
Sep 8, 2017 1:30 PM EDT
BioCentury NewsMakers In The BioTech Industry Conference
Speaker:
Rachel King
CEO
Jun 7, 2017 2:00 PM EDT
Jefferies 2017 Global Healthcare Conference
Speaker:
Rachel King
CEO
May 18, 2017 8:30 AM EDT
GLYC Corporate Update Call
Speaker:
Rachel King
CEO

To dial in and listen to the webcast by phone, please call the Participant toll free number (844) 413-7154 or Participant international number (216) 562-0466 and enter conference ID 4110139

Mar 22, 2017
GlycoMimetics CFO Brian Hahn Testifies Before House Capital Markets Subcommittee

Brian Hahn, Chief Financial Officer of GlycoMimetics, Inc., provided testimony on March 22 on behalf of the Biotechnology Innovation Organization (BIO) before the House Subcommittee on Capital Markets and Government Sponsored Enterprises. Hahn serves as the Co-Chair of BIO’s Finance & Tax Committee. Read the full press release at  http://www.businesswire.com/news/home/20170322006085/en/

Mar 7, 2017 10:00 AM EST
Cowen and Company 37th Annual Health Care Conference
Speaker:
Rachel King
CEO
Dec 5, 2016 6:00 PM PST
58th Annual American Society of Hematology (ASH) Meeting
Speaker:
Abstract 3826-Poster Session
E¬Selectin Antagonist GMI¬1271 Shows a Favorable Safety, PK and Bleeding Profile in Phase I Studies of Healthy Volunteers
Dec 5, 2016 6:00 PM PST
58th Annual American Society of Hematology (ASH) Meeting
Speaker:
Abstract 4049-Poster Session
A Phase I/II Study of GMI¬1271, a Novel E¬Selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Elderly Previously Untreated Acute Myeloid Leukemia; Results to Date
Dec 4, 2016 6:00 PM PST
58th Annual American Society of Hematology (ASH) Meeting
Speaker:
Abstract 2509-Poster Session
Rivipansel (GMI-1070) Inhibits E-Selectin Recognition of Sialyl LewisX Activation and Arrest of Human Neutrophils Expressed on CD62L (L-selectin) and Blocks Integrin
Dec 4, 2016 6:00 PM PST
58th Annual American Society of Hematology (ASH) Meeting
Speaker:
Abstract 2826-Poster Session
dministration of the Dual E-Selectin/CXCR4 Antagonist, GMI-1359, Results in a Unique Profile of Tumor Mobilization from the Bone Marrow and Facilitation of Chemotherapy in a Murine Model of FLT3 ITD AML
Dec 4, 2016 6:00 PM PST
58th Annual American Society of Hematology (ASH) Meeting
Speaker:
Abstract 3519-Poster Session
Dual E-Selectin/CXCR4 Antagonist GMI-1359 Exerts Efficient Anti-Leukemia Effects in a FLT3 ITD Mutated Acute Myeloid Leukemia Patient-Derived Xenograph Murine Model